We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+27.49%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$415B
AUM Growth
+$100B
Cap. Flow
+$4.76B
Cap. Flow %
1.15%
Top 10 Hldgs %
30.32%
Holding
11,586
New
1,443
Increased
4,471
Reduced
4,026
Closed
1,558

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.49B
2
AAPL icon
Apple
AAPL
+$1.26B
3
MSFT icon
Microsoft
MSFT
+$685M
4
TSLA icon
Tesla
TSLA
+$478M
5
NFLX icon
Netflix
NFLX
+$297M

Sector Composition

Rank Sector Weight
1 Technology 1.62%
2 Communication Services 1.38%
3 Financials 1.25%
4 Consumer Discretionary 1.12%
5 Healthcare 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
9951
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$8K ﹤0.01%
844
+169
+25% +$2.55K
VERBW
9952
DELISTED
Verb Technology Company, Inc. Warrant
VERBW
$8K ﹤0.01%
+26,496
New +$8.12K
NSPRZ
9953
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$8K ﹤0.01%
484,194
-25,610
-5% -$256
AFH
9954
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$8K ﹤0.01%
12,536
-53,160
-81% -$24.2K
SHIPW
9955
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$8K ﹤0.01%
150,137
-37,803
-20% -$877
CATX icon
9956
Perspective Therapeutics
CATX
$364M
$7K ﹤0.01%
1,342
-7,901
-85% -$50.8K
INDP icon
9957
CALL
Indaptus Therapeutics
INDP
$147M
$7K ﹤0.01%
+11
New +$6.8K
SENS icon
9958
PUT
Senseonics Holdings Inc
SENS
$484M
$7K ﹤0.01%
950
-110
-10% -$1.14K
SGLBW
9959
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
$7K ﹤0.01%
+32,926
New +$5.16K
CBL
9960
PUT
DELISTED
CBL& Associates Properties, Inc.
CBL
$7K ﹤0.01%
27,000
-6,800
-20% -$1.8K
JAGX icon
9961
Jaguar Health
JAGX
$4.79M
0
DMK
9962
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
171
-118
-41% -$4.04K
NDRAW
9963
DELISTED
ENDRA Life Sciences Inc. Warrants
NDRAW
$6K ﹤0.01%
35,297
+24,908
+240% +$4.24K
OTLKW
9964
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$6K ﹤0.01%
+20,070
New +$3.15K
KTOVW
9965
DELISTED
Kitov Pharma Ltd. Warrants
KTOVW
$6K ﹤0.01%
+30,352
New +$1.74K
ATNM icon
9966
CALL
Actinium Pharmaceuticals
ATNM
$32.6M
$5K ﹤0.01%
+510
New +$3.86K
AGIG
9967
Abundia Global Impact Group
AGIG
$41.4M
$5K ﹤0.01%
282
-5
-2% -$86
TDW.WS
9968
DELISTED
Tidewater Inc.
TDW.WS
$5K ﹤0.01%
+10,751
New +$3.59K
THWWW
9969
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$5K ﹤0.01%
46,600
TDW.WS.B
9970
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$5K ﹤0.01%
+11,679
New +$6.88K
GMO
9971
DELISTED
General Moly, Inc.
GMO
$4K ﹤0.01%
20,615
+8,275
+67% +$1.64K
VANIW
9972
DELISTED
Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
$3K ﹤0.01%
26,371
+124
+0.5% +$13
SHIPZ
9973
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$3K ﹤0.01%
46,545
+35,031
+304% +$1.11K
PHIOW
9974
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$3K ﹤0.01%
+17,569
New +$2.19K
ARTLW
9975
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$2K ﹤0.01%
+16,708
New +$2.2K

Similar funds

Jeff Yass's Q2 2020 Portfolio in Review

As of Q2 2020, Jeff Yass held 11,586 positions worth $415B, up 32% from $314B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2020 filing shows 1,443 new, 4,471 increased, 4,026 reduced and 1,558 closed positions. Its largest new stake was VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2: 1,220,649 shares worth $12.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Communication Services and Financials.

  • Jeff Yass's largest Q2 2020 buy was VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2: 1,220,649 shares worth $12.4M.
  • Jeff Yass added most to Invesco QQQ Trust in Q2 2020, an estimated $2.33B increase.
  • Jeff Yass's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.49B.
  • Jeff Yass fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $119M.
  • Jeff Yass's ten largest holdings make up 30% of its $415B portfolio in Q2 2020.
  • Jeff Yass opened 1,443 new positions and closed 1,558 in Q2 2020.
  • Jeff Yass's portfolio value rose 32% quarter-over-quarter to $415B.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.